Biotechs look to sell royalties to raise cash in a tough market

Financial Times | Oct 31, 2022 at 5:00 AM
  • …up 23 per cent year on year, according to life sciences investment bank Torreya. Pablo Legorreta, chief executive of Royalty Pharma, said interest in royalty…